
Rinol Pharmaceuticals Private Limited
This company manufactures and trades pharmaceuticals, healthcare products, and medicinal goods.
This company manufactures and trades pharmaceuticals, healthcare products, and medicinal goods.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
-
U51909MP2020PTC050659
050659
Private Limited Indian Non-Government Company
14 Jan 2020
-
-
Unlisted
Roc Gwalior
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ram Shukla ![]() | Director | 14-Jan-2020 | Current |
Ravi Tiwari ![]() | Director | 14-Jan-2020 | Current |
Enhance accessibility to Rinol Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Rinol Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Ram Shukla is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rinol Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rinol Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rinol Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ram Krishna Shukla was appointed as a Director was appointed as a Director on 14 Jan 2020 & has been associated with this company since 5 years 1 month .
Ravi Shankar Tiwari was appointed as a Director was appointed as a Director on 14 Jan 2020 & has been associated with this company since 5 years 1 month .
Rinol Pharmaceuticals Private Limited was registered on 14 Jan 2020 with Roc Gwalior & aged 5 years 1 month as per MCA records.
Rinol Pharmaceuticals Private Limited was incorporated on 14 Jan 2020.
The authorized share capital of Rinol Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Rinol Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rinol Pharmaceuticals Private Limited is 219 Loknayak Nagar Airport Road, A-Elymer, Indore, Madhya Pradesh, India, 452001.
The corporate identification number (CIN) of Rinol Pharmaceuticals Private Limited is U51909MP2020PTC050659 and the company number is 050659 as per Ministry of Corporate Affairs (MCA).